Skip to main content
Clinical Trials/CTRI/2026/03/105107
CTRI/2026/03/105107Not yet recruitingNot Applicable

Comparative Study of Homoeopathy Alone and Combined with Yoga Therapy in the Management of Menstrual Disorders in Reproductive Age Women – An Experimental Comparative Study

Dr Prajakta Pandharinath Pise1 site in 1 country1,000 target enrollmentStarted: March 18, 2026Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
1,000
Locations
1
Primary Endpoint
2. Quality of Life (QoL) Measures Physical well-being: Fatigue,sleep disturbances, physical discomfort.

Study Overview

Brief Summary

Menstrual disorders are common among women in the reproductive age group and are often associated with symptoms such as dysmenorrhea, irregular cycles, menorrhagia, premenstrual syndrome (PMS), mood disturbances, fatigue, and reduced quality of life. These conditions significantly affect physical health, psychological well-being, and daily functioning. Despite their high prevalence, menstrual health problems are frequently neglected.

Homeopathy is widely used in gynecological disorders and may help in symptom relief; however, available evidence shows mixed results and lacks large-scale comparative studies. Similarly, yoga practices including asanas, pranayama, and Yoga Nidra have demonstrated beneficial effects in reducing stress, regulating menstrual cycles, and improving overall well-being. Most previous studies focus on short-term symptomatic improvement, and limited research has compared combined therapy with single-modality treatment.

Therefore, this experimental comparative study aims to evaluate the effectiveness of homeopathy alone versus homeopathy combined with yoga therapy in the management of menstrual disorders in reproductive age women. The study intends to generate scientific evidence regarding whether integrative therapy provides superior clinical outcomes and improves overall quality of life.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant Blinded

Eligibility Criteria

Ages
15.00 Year(s) to 45.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • •female age 15-45 years Diagnosed with menstrual disorder Willing to participate and follow up regularly.

Exclusion Criteria

  • •preganant women recent surgery female diagnosed with pelvic pathologies endometriosis uterine fibroid.

Outcomes

Primary Outcomes

2. Quality of Life (QoL) Measures Physical well-being: Fatigue,sleep disturbances, physical discomfort.

Time Frame: Monthly follow-up or as per the need of the cases.

Emotional and psychological health: Anxiety, mood swings,

Time Frame: Monthly follow-up or as per the need of the cases.

Primary outcome-

Time Frame: Monthly follow-up or as per the need of the cases.

1.Symptom Reduction

Time Frame: Monthly follow-up or as per the need of the cases.

Frequency of symptoms: how often dysmenorrhea,

Time Frame: Monthly follow-up or as per the need of the cases.

PMS/menorrhagia occurs.

Time Frame: Monthly follow-up or as per the need of the cases.

Intensity of symptoms: Measured using scales like Visual Analog Scale (VAS) for pain.

Time Frame: Monthly follow-up or as per the need of the cases.

irritability (often assessed using validated scales like VAS SCALE.

Time Frame: Monthly follow-up or as per the need of the cases.

Secondary Outcomes

  • To assess the symptom reduction, frequency of symptoms, & quality of life measures.(Monthly follow-up or as per the need of the cases.)

Investigators

Sponsor
Dr Prajakta Pandharinath Pise
Sponsor Class
Research institution and hospital
Responsible Party
Principal Investigator
Principal Investigator

Prajakta Pandharinath Pise

Guru Mishri Homeopathic Medical College and hospital shelgaon, Jalna

Study Sites (1)

Loading locations...

Similar Trials

A Study to Compare the Effect of... | Clinical Trial